References(39)
[1]
Schapira, A. H. Mitochondrial disease. Lancet 2006, 368, 70-82.
[2]
Senyilmaz, D.; Virtue, S.; Xu, X. J.; Tan, C. Y.; Griffin, J. L.; Miller, A. K.; Vidal-Puig, A.; Teleman, A. A. Regulation of mitochondrial morphology and function by stearoylation of TFR1. Nature 2015, 525, 124-128.
[3]
Guarani, V.; McNeill, E. M.; Paulo, J. A.; Huttlin, E. L.; Fröhlich, F.; Gygi, S. P.; Van Vactor, D.; Harper, J. W. QIL1 is a novel mitochondrial protein required for MICOS complex stability and cristae morphology. eLife 2015, 4, e06265.
[4]
Blanco, F. J.; Rego, I.; Ruiz-Romero, C. The role of mitochondria in osteoarthritis. Nat. Rev. Rheumatol. 2011, 7, 161-169.
[5]
Yu, T. Z.; Robotham, J. L.; Yoon, Y. Increased production of reactive oxygen species in hyperglycemic conditions requires dynamic change of mitochondrial morphology. Proc. Natl. Acad. Sci. USA 2006, 103, 2653-2658.
[6]
Alirol, E.; Martinou, J. C. Mitochondria and cancer: Is there a morphological connection? Oncogene 2006, 25, 4706-4716.
[7]
Chen, Q. X.; Shao, X. T.; Tian, Z. Q.; Chen, Y.; Mondal, P.; Liu, F.; Wang, F. S.; Ling, P. X.; He, W. J.; Zhang, K. et al. Nanoscale monitoring of mitochondria and lysosome interactions for drug screening and discovery. Nano Res. 2019, 12, 1009-1015.
[8]
Hell, S. W.; Wichmann, J. Breaking the diffraction resolution limit by stimulated emission: Stimulated-emission-depletion fluorescence microscopy. Opt. Lett. 1994, 19, 780-782.
[9]
Gustafsson, M. G. L. Surpassing the lateral resolution limit by a factor of two using structured illumination microscopy. J. Microsc. 2000, 198, 82-87.
[10]
Huang, X. S.; Fan, J. C.; Li, L. J.; Liu, H. S.; Wu, R. L.; Wu, Y.; Wei, L. S.; Mao, H.; Lal, A.; Xi, P. et al. Fast, long-term, super-resolution imaging with Hessian structured illumination microscopy. Nat. Biotechnol. 2018, 36, 451-459.
[11]
Rust, M. J.; Bates, M.; Zhuang, X. W. Sub-diffraction-limit imaging by stochastic optical reconstruction microscopy (STORM). Nat. Meth. 2006, 3, 793-796.
[12]
Betzig, E.; Patterson, G. H.; Sougrat, R.; Lindwasser, O. W.; Olenych, S.; Bonifacino, J. S.; Davidson, M. W.; Lippincott-Schwartz, J.; Hess, H. F. Imaging intracellular fluorescent proteins at nanometer resolution. Science 2006, 313, 1642-1645.
[13]
Chen, Q. X.; Jin, C. Z.; Shao, X. T.; Guan, R. L.; Tian, Z. Q.; Wang, C. R.; Liu, F.; Ling, P. X.; Guan, J. L.; Ji, L. N. et al. Super-resolution tracking of mitochondrial dynamics with an iridium(III) luminophore. Small 2018, 14, 1802166.
[14]
Challa, S.; Kanikannan, M. A.; Murthy, J. M.; Bhoompally, V. R.; Surath, M. Diagnosis of mitochondrial diseases: Clinical and histological study of sixty patients with ragged red fibers. Neurol. India 2004, 52, 353-358.
[15]
Parikh, S.; Goldstein, A.; Koenig, M. K.; Scaglia, F.; Enns, G. M.; Saneto, R.; Anselm, I.; Cohen, B. H.; Falk, M. J.; Greene, C. et al. Diagnosis and management of mitochondrial disease: A consensus statement from the Mitochondrial Medicine Society. Genet. Med. 2015, 17, 689-701.
[16]
Hao, L.; Li, Z. W.; Zhang, D. Y.; He, L.; Liu, W. T.; Yang, J.; Tan, C. P.; Ji, L. N.; Mao, Z. W. Monitoring mitochondrial viscosity with anticancer phosphorescent Ir(III) complexes via two-photon lifetime imaging. Chem. Sci. 2019, 10, 1285-1293.
[17]
Mo, R.; Sun, Q.; Xue, J. W.; Li, N.; Li, W. Y.; Zhang, C.; Ping, Q. N. Multistage pH-responsive liposomes for mitochondrial-targeted anticancer drug delivery. Adv. Mater. 2012, 24, 3659-3665.
[18]
Cao, X.; Wang, H. Q.; Wang, Z.; Wang, Q. Y.; Zhang, S.; Deng, Y. P.; Fang, Y. S. In vivo imaging reveals mitophagy independence in the maintenance of axonal mitochondria during normal aging. Aging Cell 2017, 16, 1180-1190.
[19]
Berman, S. B.; Pineda, F. J.; Hardwick, J. M. Mitochondrial fission and fusion dynamics: The long and short of it. Cell Death Differ. 2008, 15, 1147-1152.
[20]
Wai, T.; Langer, T. Mitochondrial dynamics and metabolic regulation. Trends Endocrinol. Metab. 2016, 27, 105-117.
[21]
Yaffe, M. P. Dynamic mitochondria. Nat. Cell Biol. 1999, 1, E149-E150.
[22]
Arnoult, D. Mitochondrial fragmentation in apoptosis. Trends Cell Biol. 2007, 17, 6-12.
[23]
Youle, R. J.; Narendra, D. P. Mechanisms of mitophagy. Nat. Rev. Mol. Cell Biol. 2011, 12, 9-14.
[24]
Wolvetang, E. J.; Johnson, K. L.; Krauer, K.; Ralph, S. J.; Linnane, A. W. Mitochondrial respiratory chain inhibitors induce apoptosis. FEBS Lett. 1994, 339, 40-44.
[25]
Karbowski, M.; Youle, R. J. Dynamics of mitochondrial morphology in healthy cells and during apoptosis. Cell Death Differ. 2003, 10, 870-880.
[26]
Suen, D. F.; Norris, K. L.; Youle, R. J. Mitochondrial dynamics and apoptosis. Genes Dev. 2008, 22, 1577-1590.
[27]
Dixon, S. J.; Lemberg, K. M.; Lamprecht, M. R.; Skouta, R.; Zaitsev, E. M.; Gleason, C. E.; Patel, D. N.; Bauer, A. J.; Cantley, A. M.; Yang, W. S. et al. Ferroptosis: An iron-dependent form of nonapoptotic cell death. Cell 2012, 149, 1060-1072.
[28]
Xie, Y.; Hou, W.; Song, X.; Yu, Y.; Huang, J.; Sun, X.; Kang, R.; Tang, D. Ferroptosis: Process and function. Cell Death Differ. 2016, 23, 369-379.
[29]
Stockwell, B. R.; Angeli, J. P. F.; Bayir, H.; Bush, A. I.; Conrad, M.; Dixon, S. J.; Fulda, S.; Gascón, S.; Hatzios, S. K.; Kagan, V. E. et al. Ferroptosis: A regulated cell death nexus linking metabolism, redox biology, and disease. Cell 2017, 171, 273-285.
[30]
Angeli, J. P. F.; Schneider, M.; Proneth, B.; Tyurina, Y. Y.; Tyurin, V. A.; Hammond, V. J.; Herbach, N.; Aichler, M.; Walch, A.; Eggenhofer, E. et al. Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat. Cell Biol. 2014, 16, 1180-1191.
[31]
Tian, Z. Q.; Gong, J. H.; Crowe, M.; Lei, M.; Li, D.C. ; Ji, B. H.; Diao, J. J. Biochemical studies of membrane fusion at the single-particle level. Prog. Lipid Res. 2019, 73, 92-100.
[32]
Chen, Q. X.; Shao, X. T.; Hao, M. G.; Fang, H. B.; Guan, R. L.; Tian, Z. Q.; Li, M. L.; Wang, C. R.; Ji, L. N.; Chao, H. et al. Quantitative analysis of interactive behavior of mitochondria and lysosomes using structured illumination microscopy. Biomaterials 2020, 250, 120059.
[33]
Hwang, J. M.; Cho, J. S.; Kim, T. H.; Lee, Y. I. Ellagic acid protects hepatocytes from damage by inhibiting mitochondrial production of reactive oxygen species. Biomed. Pharmacother. 2010, 64, 264-270.
[34]
Li, Z.; Slone, J.; Wu, L. Q.; Huang, T. S. Neurodegenerative diseases associated with mutations in SLC25A46. In Recent Advances in Neurodegeneration; Borreca, A., Ed.; IntechOpen, 2018.
[35]
Steffen, J.; Vashisht, A. A.; Wan, J. J.; Jen, J. C.; Claypool, S. M.; Wohlschlegel, J. A.; Koehler, C. M.; Fox, T. D. Rapid degradation of mutant SLC25A46 by the ubiquitin-proteasome system results in MFN1/2-mediated hyperfusion of mitochondria. Mol. Biol. Cell 2017, 28, 600-612.
[36]
Yoshii, S. R.; Kishi, C.; Ishihara, N.; Mizushima, N. Parkin mediates proteasome-dependent protein degradation and rupture of the outer mitochondrial membrane. J. Biol. Chem. 2011, 286, 19630-19640.
[37]
Spinazzola, A.; Viscomi, C.; Fernandez-Vizarra, E.; Carrara, F.; D’Adamo, P.; Calvo, S.; Marsano, R. M.; Donnini, C.; Weiher, H.; Strisciuglio, P. et al. MPV17 encodes an inner mitochondrial membrane protein and is mutated in infantile hepatic mitochondrial DNA depletion. Nat. Genet. 2006, 38, 570-575.
[38]
Strauss, M.; Hofhaus, G.; Schröder, R. R.; Kühlbrandt, W. Dimer ribbons of ATP synthase shape the inner mitochondrial membrane. EMBO J. 2008, 27, 1154-1160.
[39]
Fang, H. B.; Yao, S. K.; Chen, Q. X.; Liu, C. Y.; Cai, Y. Q.; Geng, S. S.; Bai, Y.; Tian, Z. Q.; Zacharias, A. L.; Takebe, T. et al. De novo-designed near-infrared nanoaggregates for super-resolution monitoring of lysosomes in cells, in whole organoids and in vivo. ACS Nano 2019, 13, 14426-14436.